Linda J.W. Bosch

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)”.

Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)

Epigenetics(2022)10.1080/15592294.2022.2058225

N/A

0.111DataRank · unranked

1 citations

Ming Yu, Yuhong Zhang, Fang‐Shu Ou, Tyler Zemla, Kelly Carter +8 more

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

BMC Cancer(2020)10.1186/s12885-020-07252-y

N/A

0DataRank · unranked

59 citations

Karlijn L. van Rooijen, Dave E. W. van der Kruijssen, C. Rubio Alarcón, Jillian Phallen, Mark Sausen +52 more